Shares of Moderna Inc. MRNA slid 5.77% to $150.17 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.05% to 31,537.35 and the NASDAQ Composite Index COMP falling 0.50% to 13,465.20. This was the stock’s second consecutive day of losses. Moderna Inc. closed $39.09 below its 52-week high ($189.26), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV fell 0.74% to $106.27, Amgen Inc. AMGN rose 0.43% to $232.46, and AstraZeneca PLC ADR AZN fell 2.49% to $49.31. Trading volume (15.4 M) remained 2.6 million below its 50-day average volume of 18.0 M.